Aigerim Abilova
Aigerim Abilova has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Mirgul Bayanova
Clinical Academic Department of Laboratory Medicine, Pathology, and Genetics “University Medical Center” Corporate Fund Astana Kazakhstan
2 shared publications - Aidos Bolatov
Shenzhen University Medical School, Shenzhen University, Shenzhen, China
1 shared publication - Alissa Nauryzbayeva
Astana Medical University, Astana, Kazakhstan
1 shared publication - Assiya Bazenova
University Medical Center CF, Astana, Kazakhstan
1 shared publication - Dias Malik
“University Medical Center” Corporate Fund, Astana, Kazakhstan
1 shared publication - Lyazzat Nazarova
“University Medical Center” Corporate Fund, Astana, Kazakhstan
1 shared publication
Latest Publications
- Open Access
- 2 April 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-11
Genetic landscape and phenotypic spectrum of osteogenesis imperfecta in the Kazakhstani pediatric population
This study investigates the genetic landscape and phenotypic spectrum of osteogenesis imperfecta (OI) in the Kazakhstani pediatric population, focusing on 40 children diagnosed and treated at the “University Medical Center” Corporate Fund from July 2021 to June 2023. Genetic analysis was conducted using whole-genome sequencing for 22 participants at the “National Laboratory Astana” (Nazarbayev University, Astana, Kazakhstan) and whole-exome sequencing for 18 participants in private laboratories. Clinically significant genetic variants were found in 35 cases (87.5%). Mutations in the COL1A1 and COL1A2 genes were detected in 24 cases (68.6%), among them 5 variants were described for the first time. Among the rare cases of OI, variants in the IFITM5 (n = 2), SERPINF1 (n = 7), and SERPINH1 (n = 1) genes were identified. At the same time, seven unrelated cases had identical variants in the SERPINF1 gene (c.907C > T, 6 of which in the homozygous and 1 in the compound heterozygous state) and two cases in the IFITM1 gene (c.-14C > T). Novel disease-causing variants were identified in 17% of cases, and a higher proportion of collagen defects were seen. The relatively high proportion of autosomal recessive inherited OI determined in the current study should be investigated at the population level in Kazakhstan and in the countries of Central Asia. Moreover, this study described the genotype–phenotype correlation, which complements and expands the existing knowledge about the OI.
- 2 April 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-11
Open AccessGenetic landscape and phenotypic spectrum of osteogenesis imperfecta in the Kazakhstani pediatric population
This study investigates the genetic landscape and phenotypic spectrum of osteogenesis imperfecta (OI) in the Kazakhstani pediatric population, focusing on 40 children diagnosed and treated at the “University Medical Center” Corporate Fund from July 2021 to June 2023. Genetic analysis was conducted using whole-genome sequencing for 22 participants at the “National Laboratory Astana” (Nazarbayev University, Astana, Kazakhstan) and whole-exome sequencing for 18 participants in private laboratories. Clinically significant genetic variants were found in 35 cases (87.5%). Mutations in the COL1A1 and COL1A2 genes were detected in 24 cases (68.6%), among them 5 variants were described for the first time. Among the rare cases of OI, variants in the IFITM5 (n = 2), SERPINF1 (n = 7), and SERPINH1 (n = 1) genes were identified. At the same time, seven unrelated cases had identical variants in the SERPINF1 gene (c.907C > T, 6 of which in the homozygous and 1 in the compound heterozygous state) and two cases in the IFITM1 gene (c.-14C > T). Novel disease-causing variants were identified in 17% of cases, and a higher proportion of collagen defects were seen. The relatively high proportion of autosomal recessive inherited OI determined in the current study should be investigated at the population level in Kazakhstan and in the countries of Central Asia. Moreover, this study described the genotype–phenotype correlation, which complements and expands the existing knowledge about the OI.
- Open Access
- 12 January 2024
- Published by Wiley in Case Reports in Medicine
- Vol. 2024, 1-3
Delayed Diagnosis of Perrault Syndrome: A Rare Genetic Disorder
Perrault syndrome (PRLTS) is a rare autosomal recessive disorder which is associated with pathogenic variants in HSD17B4, HARS2, CLPP, LARS2, GGPS1, RMND1, TWNK, ERAL1, and PRORP genes. The disease is characterized by sensorineural hearing loss, sometimes with neurological signs, including progressive sensory and motor peripheral neuropathy, cerebellar ataxia, mild mental retardation, and ovarian dysgenesis in females. In this article, we report a case of a child diagnosed with spastic diplegic cerebral palsy. Determination of the segregation status of the parents of a proband with a rare compound heterozygote in the gene HSD17B4 will help the genetic counselling for the prognosis of Perrault syndrome in the family.
- 12 January 2024
- Published by Wiley in Case Reports in Medicine
- Vol. 2024, 1-3
Open AccessDelayed Diagnosis of Perrault Syndrome: A Rare Genetic Disorder
Perrault syndrome (PRLTS) is a rare autosomal recessive disorder which is associated with pathogenic variants in HSD17B4, HARS2, CLPP, LARS2, GGPS1, RMND1, TWNK, ERAL1, and PRORP genes. The disease is characterized by sensorineural hearing loss, sometimes with neurological signs, including progressive sensory and motor peripheral neuropathy, cerebellar ataxia, mild mental retardation, and ovarian dysgenesis in females. In this article, we report a case of a child diagnosed with spastic diplegic cerebral palsy. Determination of the segregation status of the parents of a proband with a rare compound heterozygote in the gene HSD17B4 will help the genetic counselling for the prognosis of Perrault syndrome in the family.